Innate Pharma S.A. (IPHA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 133.18M |
| Enterprise Value | 127.66M |
| P/E Ratio | -2.93 |
| PEG Ratio | -0.3 |
| Price/Sales Ratio | 54.38 |
| Price/Book Ratio | -6.8 |
| Enterprise/Revenue | 52.4 |
| Enterprise/EBITDA | -2.61 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -17.65 |
| Operating Margin | -20.58 |
| Return On Assets | -0.78 |
| Return On Equity | 5.94 |
| Revenue | 2.79M |
| Revenue/Share | 0.03 |
| Gross Profit | 2.79M |
| EBITDA | -43.65M |
| Net Income | -49.18M |
| Diluted EPS | -0.53 |
| Total Cash | 34.3M |
| Total Cash/Share | 0.38 |
| Total Debt | 22.56M |
| Total Debt/Equity | -1.04 |
| Current Ratio | 1.27 |
| Book Value Per Share | -0.24 |
| 52-Week Change | 0.56 |
| 52-Week High | 2.63 |
| 52-Week Low | 1.17 |
| Moving Average 50 Days | 1.67 |
| Moving Average 200 Days | 1.76 |
| Average Volume | 73,819 |
| Shares Outstanding | 93.9M |
| % Held by Institutions | 0.2 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |